![Maria Feldman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Maria Feldman
Keine laufenden Positionen mehr
Karriereverlauf von Maria Feldman
Ehemalige bekannte Positionen von Maria Feldman
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Neothetics, Inc.
![]() Neothetics, Inc. Pharmaceuticals: MajorHealth Technology Neothetics, Inc. operates as a holding company, which provides clinical-stage specialty pharmaceutical and developing therapeutics for the aesthetic. It focuses on localized fat reduction and body contouring. The company products include LIPO-202, is an injectable formulation of the long-acting ß2-adrenergic receptor agonist, salmeterol xinafoate. Neothetics was founded by John D. Dobak in February 2007 and is headquartered in San Diego, CA. | Geschäftsführer | 01.03.2014 | - |
Technik-/Wissenschafts-/F&E-Leiter | 01.03.2014 | - | |
General Counsel | 01.02.2016 | - | |
EVOFEM BIOSCIENCES, INC. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
General Counsel | - | - | |
MEDICINOVA, INC. | General Counsel | 01.01.2004 | - |
Ausbildung von Maria Feldman
St. Olaf College | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 5 |
Operativ
General Counsel | 3 |
Chief Tech/Sci/R&D Officer | 2 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
MEDICINOVA, INC. | Health Technology |
EVOFEM BIOSCIENCES, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Neothetics, Inc.
![]() Neothetics, Inc. Pharmaceuticals: MajorHealth Technology Neothetics, Inc. operates as a holding company, which provides clinical-stage specialty pharmaceutical and developing therapeutics for the aesthetic. It focuses on localized fat reduction and body contouring. The company products include LIPO-202, is an injectable formulation of the long-acting ß2-adrenergic receptor agonist, salmeterol xinafoate. Neothetics was founded by John D. Dobak in February 2007 and is headquartered in San Diego, CA. | Health Technology |
- Börse
- Insiders
- Maria Feldman
- Erfahrung